Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Egerton, M.
Right arrow Articles by Kelso, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egerton, M.
Right arrow Articles by Kelso, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 10, 223-229, Copyright © 1998 by Oxford University Press


ARTICLES

Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes

M Egerton, DR Fitzpatrick and A Kelso
The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia.

The extracellular signal-regulated kinase (ERK) signaling pathway is strongly activated in response to TCR stimulation in normal T cells. However, the extent to which activation of the ERK pathway is necessary for TCR-stimulated cytokine production is not clear. We have addressed this question by use of two separate methods to interfere with TCR activation of the ERK cascade. The first approach utilized transient expression of a catalytically inactive form of mitogen-activated/ERK 1 (CI-MEK1), while the second involved using the MEK1- and MEK2-specific inhibitor PD98059 to block ERK activation by the TCR. In order to assess the requirement for ERK activation in T cell cytokine production, we have measured the effect of ERK inhibition upon the production of six cytokines, IL-3, IL-4, IL-5, IL-10, granulocyte macrophage colony stimulating factor (GM-CSF) and IFN-gamma, by newly activated normal mouse T cells in response to TCR stimulation. The results of experiments using both methods to block ERK activation have revealed a requirement for intact ERK signaling for the full elicitation of TCR-stimulated cytokine production. Dose-response analyses using the MEK inhibitor PD98059 showed that the TCR-stimulated production of all cytokines measured was affected by this treatment. However, the production of IL-3 and IL-4 was only partially dependent upon ERK activation, whereas IL-5, IL-10, IFN-gamma and GM-CSF production was severely affected by diminished ERK activation. We conclude that the ERK pathway is differentially involved in the activation of different cytokine genes in normal T cells.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Suzuki, T. Shimizu, H.-P. Yu, Y.-C. Hsieh, M. A. Choudhry, and I. H. Chaudry
Salutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor-{alpha}
Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2103 - C2111.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Wang, M. F. Shannon, and I. G. Young
A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes
Int. Immunol., February 1, 2006; 18(2): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Cannarile, F. Fallarino, M. Agostini, S. Cuzzocrea, E. Mazzon, C. Vacca, T. Genovese, G. Migliorati, E. Ayroldi, and C. Riccardi
Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines
Blood, February 1, 2006; 107(3): 1039 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Lowenberg, A. Verhaar, B. van den Blink, F. ten Kate, S. van Deventer, M. Peppelenbosch, and D. Hommes
Specific Inhibition of c-Raf Activity by Semapimod Induces Clinical Remission in Severe Crohn's Disease
J. Immunol., August 15, 2005; 175(4): 2293 - 2300.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Inoue, R. Kato, S. Fukuyama, A. Nonami, K. Taniguchi, K. Matsumoto, T. Nakano, M. Tsuda, M. Matsumura, M. Kubo, et al.
Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness
J. Exp. Med., January 3, 2005; 201(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. N. Johnson, E. R. Appelbaum, D. C. Carptenter, R. F. Cox, J. Disa, J. J. Foley, S. K. Ghosh, D. P. Naselsky, M. A. Pullen, H. M. Sarau, et al.
Neuromedin Elicits Cytokine Release in Murine Th2-Type T Cell Clone D10.G4.1
J. Immunol., December 15, 2004; 173(12): 7230 - 7238.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. K. Singh and J. Z. Zhang
Differential Activation of ERK, p38, and JNK Required for Th1 and Th2 Deviation in Myelin-Reactive T Cells Induced by Altered Peptide Ligand
J. Immunol., December 15, 2004; 173(12): 7299 - 7307.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. E. Battle and D. A. Frank
STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1
Blood, October 15, 2003; 102(8): 3016 - 3024.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Faroudi, R. Zaru, P. Paulet, S. Muller, and S. Valitutti
Cutting Edge: T Lymphocyte Activation by Repeated Immunological Synapse Formation and Intermittent Signaling
J. Immunol., August 1, 2003; 171(3): 1128 - 1132.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Jorritsma, J. L. Brogdon, and K. Bottomly
Role of TCR-Induced Extracellular Signal-Regulated Kinase Activation in the Regulation of Early IL-4 Expression in Naive CD4+ T Cells
J. Immunol., March 1, 2003; 170(5): 2427 - 2434.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
I. Hecht, L. Cahalon, R. Hershkoviz, A. Lahat, S. Franitza, and O. Lider
Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis
Int. Immunol., January 1, 2003; 15(1): 29 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Costabile, C. S. T. Hii, B. S. Robinson, D. A. Rathjen, M. Pitt, C. Easton, R. C. Miller, A. Poulos, A. W. Murray, and A. Ferrante
A Novel Long Chain Polyunsaturated Fatty Acid, {beta}-Oxa 21:3n-3, Inhibits T Lymphocyte Proliferation, Cytokine Production, Delayed-Type Hypersensitivity, and Carrageenan-Induced Paw Reaction and Selectively Targets Intracellular Signals
J. Immunol., October 1, 2001; 167(7): 3980 - 3987.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. J. Staples, M. Bergmann, K. Tomita, M. D. Houslay, I. McPhee, P. J. Barnes, M. A. Giembycz, and R. Newton
Adenosine 3',5'-Cyclic Monophosphate (cAMP)-Dependent Inhibition of IL-5 from Human T Lymphocytes Is Not Mediated by the cAMP-Dependent Protein Kinase A
J. Immunol., August 15, 2001; 167(4): 2074 - 2080.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bostik, A. E. Mayne, F. Villinger, K. P. Greenberg, J. D. Powell, and A. A. Ansari
Relative Resistance in the Development of T Cell Anergy in CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys
J. Immunol., January 1, 2001; 166(1): 506 - 516.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. R. Fitzpatrick, K. M. Shirley, L. E. McDonald, H. Bielefeldt-Ohmann, G. F. Kay, and A. Kelso
Distinct Methylation of the Interferon {gamma} (IFN-{gamma}) and Interleukin 3 (IL-3) Genes in Newly Activated Primary CD8+ T Lymphocytes: Regional IFN-{gamma} Promoter Demethylation and mRNA Expression Are Heritable in CD44highCD8+ T Cells
J. Exp. Med., July 1, 1998; 188(1): 103 - 117.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.